StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.82−0.17 (-8.42%)

Close on Nov 17, 2026Market cap $2.65MP/E –Yield –

Nexentis Technologies total assets

Total assets on the balance sheet at the end of each period.

Nexentis Technologies's total assets was $18.69M at Jun 30, 2026. For fiscal 2025 it was $20.41M, up 273.4% from the year before. The highest annual figure on record is $20.41M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.41M+273.4%
FY2024Dec 31, 2024$5.47M-24.6%
FY2023Dec 31, 2023$7.24M+11.6%
FY2022Dec 31, 2022$6.49M-14.5%
FY2021Dec 31, 2021$7.60M+1004.8%
FY2020Dec 31, 2020$687.65K+3.5%
FY2019Dec 31, 2019$664.67K-22.6%
FY2018Dec 31, 2018$859.21K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.69M+141.1%
Q1 FY2026Mar 31, 2026$16.40M+122.7%
Q4 FY2025Dec 31, 2025$20.41M+273.4%
Q3 FY2025Sep 30, 2025$11.03M+89.4%
Q2 FY2025Jun 30, 2025$7.75M+3.6%
Q1 FY2025Mar 31, 2025$7.37M+17.5%
Q4 FY2024Dec 31, 2024$5.47M-24.6%
Q3 FY2024Sep 30, 2024$5.82M+10.9%
Q2 FY2024Jun 30, 2024$7.48M+21.4%
Q1 FY2024Mar 31, 2024$6.27M+14.5%
Q4 FY2023Dec 31, 2023$7.24M+11.6%
Q3 FY2023Sep 30, 2023$5.25M-33.4%
Q2 FY2023Jun 30, 2023$6.16M+14.3%
Q1 FY2023Mar 31, 2023$5.47M-17.3%
Q4 FY2022Dec 31, 2022$6.49M-14.5%
Q3 FY2022Sep 30, 2022$7.89M-10.8%
Q2 FY2022Jun 30, 2022$5.39M-47.5%
Q1 FY2022Mar 31, 2022$6.62M+651.6%
Q4 FY2021Dec 31, 2021$7.60M+1004.8%
Q3 FY2021Sep 30, 2021$8.84M+1415.5%
Q2 FY2021Jun 30, 2021$10.27M+2813.3%
Q1 FY2021Mar 31, 2021$880.79K+85.3%
Q4 FY2020Dec 31, 2020$687.65K+3.5%
Q3 FY2020Sep 30, 2020$583.36K-32.1%
Q2 FY2020Jun 30, 2020$352.68K–
Q1 FY2020Mar 31, 2020$475.34K–
Q4 FY2019Dec 31, 2019$664.67K–
Q4 FY2018Dec 31, 2018$859.21K–

More Nexentis Technologies figures

See a number that looks wrong?